HURA (TuHURA Biosciences) FCF Yield % : -6.79 (As of Apr. 07, 2025)

View and export this data going back to 2024. Start your Free Trial

What is TuHURA Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, TuHURA Biosciences's Trailing 12-Month Free Cash Flow is $-10.79 Mil, and Market Cap is $159.00 Mil. Therefore, TuHURA Biosciences's FCF Yield % for today is -6.79%.

The historical rank and industry rank for TuHURA Biosciences's FCF Yield % or its related term are showing as below:

HURA' s FCF Yield % Range Over the Past 10 Years
Min: -8.4 Med: 0 Max: 0
Current: -6.79

HURA's FCF Yield % is ranked better than
64.26% of 1497 companies
in the Biotechnology industry
Industry Median: -16.25 vs HURA: -6.79

TuHURA Biosciences's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

TuHURA Biosciences FCF Yield % Historical Data

The historical data trend for TuHURA Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences FCF Yield % Chart

TuHURA Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-8.54

TuHURA Biosciences Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of TuHURA Biosciences's FCF Yield %

For the Biotechnology subindustry, TuHURA Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's FCF Yield % falls into.

Save Embed

;

Save Embed

;

TuHURA Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

TuHURA Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-14.786	/	173.09698
	=	-8.54%

TuHURA Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	173.09698
	=	0.00%

TuHURA Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

TuHURA Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

TuHURA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612

Website

https://www.tuhurabio.com

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.